HRP20020480B1 - Process for the purification of pharmacologically active proteins through cationic exchange chromatography - Google Patents

Process for the purification of pharmacologically active proteins through cationic exchange chromatography

Info

Publication number
HRP20020480B1
HRP20020480B1 HR20020480A HRP20020480A HRP20020480B1 HR P20020480 B1 HRP20020480 B1 HR P20020480B1 HR 20020480 A HR20020480 A HR 20020480A HR P20020480 A HRP20020480 A HR P20020480A HR P20020480 B1 HRP20020480 B1 HR P20020480B1
Authority
HR
Croatia
Prior art keywords
purification
exchange chromatography
pharmacologically active
cationic exchange
proteins
Prior art date
Application number
HR20020480A
Other languages
English (en)
Croatian (hr)
Inventor
Scapol Lucia
Claudio Viscomi Giuseppe
Original Assignee
Alfa Wassermann S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann S.P.A. filed Critical Alfa Wassermann S.P.A.
Publication of HRP20020480A2 publication Critical patent/HRP20020480A2/hr
Publication of HRP20020480B1 publication Critical patent/HRP20020480B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20020480A 2001-07-06 2002-05-31 Process for the purification of pharmacologically active proteins through cationic exchange chromatography HRP20020480B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001BO000426A ITBO20010426A1 (it) 2001-07-06 2001-07-06 Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico

Publications (2)

Publication Number Publication Date
HRP20020480A2 HRP20020480A2 (en) 2003-02-28
HRP20020480B1 true HRP20020480B1 (en) 2006-11-30

Family

ID=11439471

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020480A HRP20020480B1 (en) 2001-07-06 2002-05-31 Process for the purification of pharmacologically active proteins through cationic exchange chromatography

Country Status (27)

Country Link
US (1) US6866782B2 (sh)
EP (1) EP1273592B1 (sh)
JP (1) JP3940037B2 (sh)
KR (1) KR100771252B1 (sh)
CN (1) CN100484954C (sh)
AR (1) AR034663A1 (sh)
AT (1) ATE307824T1 (sh)
BG (1) BG65748B1 (sh)
BR (1) BR0202431A (sh)
CA (1) CA2388716C (sh)
CU (1) CU23149A3 (sh)
DE (1) DE60206847T2 (sh)
DK (1) DK1273592T3 (sh)
DZ (1) DZ3236A1 (sh)
EG (1) EG23150A (sh)
ES (1) ES2250544T3 (sh)
HR (1) HRP20020480B1 (sh)
HU (1) HUP0202124A2 (sh)
IT (1) ITBO20010426A1 (sh)
ME (1) MEP3408A (sh)
MX (1) MXPA02006303A (sh)
PL (1) PL209954B1 (sh)
RS (1) RS51512B (sh)
RU (1) RU2274471C2 (sh)
SI (1) SI1273592T1 (sh)
SK (1) SK287827B6 (sh)
UY (1) UY27354A1 (sh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007500852A (ja) * 2003-05-16 2007-01-18 クリオバイオフィジカ， インコーポレイテッド 外部勾配クロマトフォーカシング
WO2005100379A1 (ja) * 2004-03-30 2005-10-27 Hiroshi Yanagisawa タンパク質の分離方法
US7943046B2 (en) * 2004-10-01 2011-05-17 Agilent Technologies, Inc Methods and systems for on-column protein delipidation
US7449116B2 (en) * 2004-10-01 2008-11-11 Agilent Technologies, Inc. Methods and systems for protein separation
JP5033177B2 (ja) * 2006-04-12 2012-09-26 サビエント ファーマセウティカルズ インク． 陽イオン界面活性剤によるタンパク質の精製
CA2708291A1 (en) * 2007-12-10 2009-06-18 National Research Council Of Canada Production of recombinant interferon proteins
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta
CN101768601B (zh) * 2010-02-01 2013-08-07 山东泉港药业有限公司 一种重组人血白蛋白—干扰素α2b的生产方法
US9783570B2 (en) * 2011-07-01 2017-10-10 Hoffmann-La Roche Inc. Method for separation of monomeric polypeptides from aggregated polypeptides
US8921113B2 (en) 2012-12-21 2014-12-30 Dionex Corporation Buffer kit and method of generating a linear pH gradient
RU2768003C2 (ru) * 2013-03-08 2022-03-22 Джензим Корпорейшн Интегрированное непрерывное производство терапевтических белковых лекарственных веществ
CN104236983A (zh) * 2013-06-14 2014-12-24 中国科学院大连化学物理研究所 溶液样品中含长烷基链的离子液体的去除方法
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
WO2016079598A1 (en) * 2014-11-18 2016-05-26 Unichem Laboratories Limited An improved process for the preparation of pharmacopoeial grade interferon alpha 2b
CN106496302B (zh) * 2015-09-08 2021-12-10 三生国健药业（上海）股份有限公司 一种用离子交换层析纯化蛋白质的方法
GB201517450D0 (en) * 2015-10-02 2015-11-18 Ipsen Biopharm Ltd Method
CN108367245A (zh) * 2015-12-09 2018-08-03 巴斯夫欧洲公司 在解吸条件下从发酵固体纯化蛋白质的方法
GB2568936B (en) 2017-12-01 2019-12-25 Ford Global Tech Llc Liquid cooled injector
JP2021536353A (ja) 2018-08-31 2021-12-27 ジェンザイム・コーポレーション 無菌クロマトグラフィー樹脂および製造方法におけるその使用
US11022585B2 (en) 2019-06-09 2021-06-01 Dionex Corporation Methods and systems for optimizing buffer conditions with liquid chromatography
CN111138523A (zh) * 2019-12-10 2020-05-12 天津生机集团股份有限公司 一种从重组鸡干扰素α复性液中纯化制备重组鸡干扰素α的方法
CN113968900B (zh) * 2020-07-23 2023-07-25 中元汇吉生物技术股份有限公司 一种纯化C1q蛋白的方法
CN115918902A (zh) * 2022-12-19 2023-04-07 新疆农业科学院农业质量标准与检测技术研究所 一种通过微水波扩散重力法预处理葡萄脱水并获取高酚葡萄提取物的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4534906A (en) * 1982-11-01 1985-08-13 Genentech, Inc. Removal of impurities from human leukocyte interferon preparations
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
US4732683A (en) * 1986-12-02 1988-03-22 Biospectrum, Inc. Purification method for alpha interferon
US4765903A (en) * 1987-10-06 1988-08-23 Interferon Sciences, Inc. Purification of monomeric interferon
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
US5849874A (en) * 1991-07-12 1998-12-15 Gist-Brocades, N.V. Process for the purification of serum albumin
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
EP1104809A1 (en) * 1994-04-09 2001-06-06 F. Hoffmann-La Roche Ag Process for producing alpha-interferon
JP3702474B2 (ja) * 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
US5486470A (en) * 1994-07-21 1996-01-23 Merck & Co., Inc. Purified herpes simplex virus protease and methods of purification
ES2211889T3 (es) 1994-08-31 2004-07-16 Mitsubishi Pharma Corporation Procedimiento para la purificacion de albumina de suero recombinante.
EP1736483A3 (en) * 1995-09-07 2008-07-30 Pharming Intellectual Property BV Purification of alpha-1 proteinase inhibitor
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process

Also Published As

Publication number Publication date
BG65748B1 (bg) 2009-09-30
BG106768A (en) 2003-05-30
MEP3408A (en) 2010-10-10
AR034663A1 (es) 2004-03-03
CA2388716A1 (en) 2003-01-06
JP3940037B2 (ja) 2007-07-04
SI1273592T1 (sl) 2006-02-28
EP1273592A2 (en) 2003-01-08
HRP20020480A2 (en) 2003-02-28
EP1273592B1 (en) 2005-10-26
YU50502A (sh) 2005-09-19
ES2250544T3 (es) 2006-04-16
PL354769A1 (en) 2003-01-13
DZ3236A1 (fr) 2005-04-20
US6866782B2 (en) 2005-03-15
HU0202124D0 (sh) 2002-09-28
KR20030005005A (ko) 2003-01-15
SK8592002A3 (en) 2003-01-09
CU23149A3 (es) 2006-06-29
CN100484954C (zh) 2009-05-06
RS51512B (sr) 2011-06-30
JP2003096092A (ja) 2003-04-03
DE60206847T2 (de) 2006-07-06
DK1273592T3 (da) 2006-01-02
CA2388716C (en) 2008-01-08
RU2274471C2 (ru) 2006-04-20
PL209954B1 (pl) 2011-11-30
UY27354A1 (es) 2003-04-30
ITBO20010426A0 (it) 2001-07-06
RU2002117383A (ru) 2004-01-27
HUP0202124A2 (hu) 2003-10-28
SK287827B6 (sk) 2011-11-04
DE60206847D1 (de) 2005-12-01
EG23150A (en) 2004-05-31
ITBO20010426A1 (it) 2003-01-06
CN1396176A (zh) 2003-02-12
US20030010715A1 (en) 2003-01-16
BR0202431A (pt) 2003-09-09
KR100771252B1 (ko) 2007-10-30
EP1273592A3 (en) 2003-03-19
ATE307824T1 (de) 2005-11-15
MXPA02006303A (es) 2003-02-10

Similar Documents

Publication Publication Date Title
HRP20020480B1 (en) Process for the purification of pharmacologically active proteins through cationic exchange chromatography
BR9910332A (pt) Polipeptìdio, composição, método para purificação de polipeptìdio a partir de uma composição e método para purificação de um anticorpo a partir de uma composição
UA99263C2 (ru) СПОСОБ ОЧИСТКИ Fc-СЛИТОГО БЕЛКА
PT813541E (pt) Processo de producao de uma proteina
SI2840090T1 (en) Purification of the antibody by cation exchange chromatography
BR0313131A (pt) Processo para a purificação de preproinsulina
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
AR074015A1 (es) Purificacion de proteinas acidas utilizando cromatografia de hidroxiapatita ceramica
ATE359301T1 (de) Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
BR0309992A (pt) Método para purificar albumina de soro humano recombinante (rhsa) de uma solução
BR0312521A (pt) Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado
HRP20020650B1 (en) PURIFIED hCG
PT1062244E (pt) Metodos melhorados para produzir proteinas do factor viii
PT840746E (pt) Metodo para purificacao de proteinas
BRPI0417252A (pt) processo de purificação de beta interferon humano
DK0938501T3 (da) Fremgangsmåde til oprensning af human interleukin-1 receptorantagonist fra rekombinant E. coli
WO2002004512A3 (en) Purification of human troponin i
ATE540974T1 (de) Reinigung des rekombinanten menschlichen faktors xiii
BR0007186A (pt) Processo para produzir uma "forma livre", biologicamente ativa, purificada, de gama interferon humano (hig) recombinante
FR2829636B1 (fr) Procede de qualification de codes correcteurs d'erreurs, procede d'optimisation, codeur, decodeur et application correspondants

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20110426

Year of fee payment: 10

PBON Lapse due to non-payment of renewal fee

Effective date: 20120601